Connecticut Adds Eight New Qualifying Medical Cannabis Conditions

Connecticut officials have added eight new conditions to the list that qualifies an individual to become a legal consumer of medical cannabis.

On Tuesday Connecticut’s Department of Consumer Protection announced an expansion of the state’s medical cannabis program which will significantly increase the number of people eligible to take part in it.  The move – which is expected to be made final by the Secretary of State’s office within a week – takes the state’s already expansive list of qualifying conditions and adds eight more (six for those 18+ and two for minors).

The Department added the following conditions for those 18 and older:

Spasticity — continuously contracting muscles — or neuropathic pain associated with fibromyalgia Severe rheumatoid arthritis Post herpetic neuralgia — a complication of shingles caused by chickenpox Hydrocephalus, or water on the brain, with intractable headache Intractable headache syndromes Neuropathic facial pain

For those under 18, the following conditions were added:

Muscular dystrophy Osteogenesis imperfecta

“Now that these regulations have been accepted, more patients with severe medical conditions will have access to medical marijuana as a treatment option,” said Consumer Protection Commissioner Michelle H. Seagull in a recent statement. “I want to thank our

Read More Here...

Report Shows Nearly 90 Percent of Illegal Cannabis Farms Use Toxic Pesticides

According to new reports from federal authorities and researchers, there has been a dramatic increase in the number of illegal marijuana grows in California that are using dangerous pesticides. As a result, researchers said these illegal grows are harming animals and poisoning water sources.

Increase in Dangerous Chemicals

As reported by the Associated Press, new stats show that roughly nine out of 10 illegal cannabis grow sites are using dangerous chemicals in the cultivation process, including toxic pesticides, fungicides, and fertilizers.

These new stats represent a dramatic increase in the number of grows using harmful chemicals. For example, today’s rate of chemical use is reportedly six times higher than it was in 2012. And last year, 75 percent of illegal grows were using dangerous chemicals. Clearly, the number of sites using these types of chemicals has been steadily climbing.

According to researchers, when illegal grows use chemicals it can pose a significant risk to the local environment. In particular, pesticides and other similar toxins often end up poisoning local wildlife. Additionally, these chemicals leach into water sources, where they harm fish and spread toxins further downstream.

In some cases, researchers said that pesticides were being added directly to irrigation waters. Obviously,

Read More Here...

Tell Facebook to stop censoring organizations like ours

Sign the petition and urge Facebook to stop its discriminatory practices

In the age of social media, Facebook seems to be living in the past when it comes to its attitude towards marijuana. In addition to rejecting advertising from numerous legal marijuana businesses, the platform is unfairly suspending pages and “shadow banning” organizations like ours, making it difficult for supporters to find us and see our content.

Facebook should know better. Poll after poll shows that an overwhelming majority of Americans oppose marijuana prohibition. And dozens of states have legalized marijuana in one form or another. By restricting legal marijuana businesses and advocacy organizations from fully utilizing their site, Facebook is siding with prohibitionists and tilting the social media landscape in their favor.

We are joining the National Cannabis Industry Association in urging our allies to call on Facebook to immediately change its policies. Sign the petition to end the discrimination against legal marijuana businesses and advocacy groups like ours.

Thank you for taking action. Please share this email and the petition with others. We will continue to fight back until Facebook changes its policies, so stay tuned for further updates.


Read More Here...

Discover the Sleep Promoting Benefits of CBD Gummies

Having difficulties sleeping at night? CBD gummies are a natural alternative promoting various health benefits including a better good night’s sleep!

Insomnia affects 1 in every three people. That’s a staggering statistic that shines light on this worrying issue. People aren’t getting the sleep that they need to perform their best at school, work, and to live a healthy lifestyle. There are tons of phony medications on the market that claim to help promote sleep, but often they are placebos or contain unwanted side effects. Luckily, there’s an alternative! CBD gummies are the latest and greatest supplements for helping you sleep better; and the best part is they are completely natural and delicious!

What is CBD?

Before we dive into how CBD gummies can help you catch up on that much needed sleep, let’s begin by discussing what exactly CBD is. CBD, the acronym for cannabidiol, is one of over 60 cannabinols specific to cannabis. It is predominantly found in hemp plants which are a derivative of cannabis containing high amounts of CBD and low amounts of tetrahydrocannabinol (THC), the cannabinol associated with marijuana.

CBD is non-psychoactive, meaning that it won’t get you high. Not to mention it is legal in

Read More Here...

Australia Pushes for Easier Cannabis Access in Face of “Hidden” Opioid Epidemic

Medical cannabis advocates in Australia are calling for easier access to medicinal marijuana products, citing reports that deaths from sleeping and anxiety pills have become a “hidden epidemic.”

Reports Show Opioid Deaths in Australia Are On the Rise

A recent report released by the Penington Institute showed that deaths from sleeping and anxiety pills, opioids, and methamphetamine have all risen sharply in Australia.

Penington Institute chief executive officer John Ryan said the figures were alarming. “We are seeing a surge of drug overdose deaths and this is concerning,” he said.

According to a separate report, opioid-related deaths in Australia nearly doubled from 2007 to 2016. The National Drug and Alcohol Research Centre at UNSW in Sydney released a report stating that 1,045 Australians died of opioid overdoses in 2016. Of the 1,045 opioid overdose deaths, 76 percent were attributed to pharmaceutical opioids.

Australians Want Easier Access to Medical Cannabis

Manufacturers of alternative medicines say medical cannabis products should be made more accessible to patients as an alternative to opioids and other pharmaceuticals. Medicinal marijuana has been legal in Australia since 2016, but many eligible patients around the country still have difficulty accessing it.

Medical cannabis advocate and entrepreneur Elisabetta Faenza

Read More Here...

Bill to Legalize Cannabis in Northern Mariana Islands Lands on Governor’s Desk

After its back-and-forth journey between the Commonwealth of the Northern Mariana Islands’ two legislative chambers, a bill to move the U.S. territory from total cannabis prohibition to full legalization is headed to the desk of Republican Gov. Ralph Deleon Guerrero Torres. SB 20-62 passed the CNMI House earlier this month. Today, the Senate voted without opposition to approve the bill and send it to the governor. CNMI senators say it took just 6 minutes to pass the bill. Now, Gov. Torres has four weeks to either sign the bill into law or veto it. If Torres fails to act on the legislation, it will automatically become law.

U.S. Territory Poised To Make Legal Weed History

The Commonwealth of the Northern Mariana Islands is a U.S. territory comprised of 15 islands. It resides in the Pacific ocean south of Japan, east of the Philippines, and north of Papua New Guinea. CNMI’s nearest neighbor is an island to the south, the U.S. territory of Guam. Nearly 6,000 miles of open ocean separate it from the coast of California. But that doesn’t mean residents and lawmakers haven’t been keeping a close watch on legalization efforts on the continental mainland.

In fact, the success

Read More Here...

Senate Showdown 2018: 12 Important Races to Watch

With the Republicans’ 51-49 edge in the Senate, the Democrats need to gain at least two seats on November 6. Here are 12 critical races. REPUBLICAN TO DEMOCRAT

Four Democrats hope to flip seats from Republican control:

Arizona Congresswoman Kyrsten Sinema

Arizona: Representative Kyrsten Sinema (D) vs. Representative Martha McSally

Three-term Congresswoman and a former Arizona State Representative Sinema, who’s bisexual, is aiming to win the seat of outgoing Senator Jeff Flake (R). In the state’s Aug. 28 Democratic primary, she coasted with 80% support. Her Republican rival, Congresswoman McSally, won with 53% of the vote. As of June 30, Sinema ($9.5 million) had more than twice as much campaign donations as McSally ($4.2 million). The race is considered a toss-up.

Nevada Congresswoman Jacky Rosen

Nevada: Representative Jacky Rosen (D) vs. Senator Dean Heller (R)

One-term Congresswoman Rosen is challenging Senator Heller, who’s the incumbent. In the state’s June 12 primary, both candidates won by more than 70% margins. As of June 30, both campaigns had raised in excess of $8 million. While this is viewed as a seat the Democrats can win, the race is considered a toss-up.

Former Tennessee governor Phil Bredesen

Tennessee: Phil Bredesen

Read More Here...

Elizabeth Warren Predicts Vote on Marijuana Bill if Democrats Take Senate

Sen. Elizabeth Warren (D-Mass.) has predicted that the U.S. Senate will vote on a pending marijuana legalization bill if the Democratic Party takes control of the legislative body in November’s election. The senator made the comments during an interview with Rolling Stone.

Warren and Sen. Cory Gardner (D-Colo.) introduced the Strengthening the Tenth Amendment Through Entrusting States, or STATES, Act in June of this year. If passed, the bill would amend the Controlled Substances Act so that it is no longer applicable to statutes “relating to the manufacture, production, possession, distribution, dispensation, administration, or delivery of” cannabis.

“I feel confident that if the Democrats recapture the Senate we’ll get a vote on this, and the vote will carry,” Warren said. “I think we’ve got the votes for this.”

Protection From Jeff Sessions

The senator went on to say that she is trying to protect her constituents who are complying with Massachusetts state law from prosecution by the federal government.

“I care about this marijuana bill because I care about people in my home state who are at risk of getting arrested by Jeff Sessions for either buying marijuana or running a marijuana business,” said Warren. “And I also care about when a state decides that marijuana

Read More Here...

Former Mayor of Los Angeles Antonio Villaraigosa Joins MedMen Board

Antonio Villaraigosa, the former mayor of Los Angeles, has been named to the board of directors of cannabis retailer and producer MedMen. The company, which is based in Los Angeles, operates 19 licensed cannabis facilities in three states.

“I’m excited for this opportunity to shape the cannabis industry and its commitment to social equity by joining the board of the company that is leading the charge,” Villaraigosa said on Wednesday in a press release.

Adam Bierman, the CEO of MedMen, said that the company will tap into Villaraigosa’s experience and network of political and business contacts in Los Angeles and the state of California.

“California is the largest legal cannabis market in the world, and Los Angeles is the epicenter of our fast-evolving industry,” said Bierman.

“Few people understand Los Angeles and our home state better than Mayor Villaraigosa. He will be instrumental in guiding MedMen’s expansion in the Golden State and through his broad network, Mr. Villaraigosa will help MedMen solidify its presence across the country. He has dedicated his career to empowering local communities, and we look forward to his leadership,” he added.

Commitment To Social Equity

In an interview with the Los Angeles Times, Villaraigosa said that he plans to

Read More Here...

China’s Drug Control Agency Denies Trump’s Allegations of Supplying Fentanyl to US

On August 20, President Trump blamed China for supplying the synthetic opioid fentanyl that’s devastating U.S. communities. In a strongly-worded tweet, Trump accused China of moving the drug through the U.S. Postal System. The tweet marks the second time Trump has accused China of playing a role in the U.S.’s ongoing opioid crisis, and China’s Drug Control Agency’s rejection of those claims marks the second time they’ve disputed them. Evidence to support Trump’s claims has not been provided, Beijing officials say. This back-and-forth is once again heightening the already-tense relations between the two nations.

China Again Denies “Flooding” the U.S. with Fentanyl

Prior to his November 2017 visit to China, President Trump claimed that China was the producer of most of the synthetic opioid fentanyl coming into the United States. He also stated that he would discuss the issue with President Xi Jinping at their Beijing meeting. And just days ahead of the visit, Chinese officials rejected Trump’s claim.

Wei Xiaojun, deputy director general of the Narcotics Control Bureau of the Ministry of Public Security, acknowledged that in some individual cases, fentanyl manufactured illicitly in China had ended up in the United States. But Wei expressly denied the claim that

Read More Here...